TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
- PMID: 24800739
- PMCID: PMC4011756
- DOI: 10.1371/journal.pone.0096630
TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)
Abstract
Background: TIMI frame count (TFC) predicts outcomes in patients with obstructive coronary artery disease (CAD); it remains unclear whether TFC predicts outcomes in patients without obstructive CAD.
Methods: TFC was determined in a sample of women with no obstructive CAD enrolled in the Women's Ischemia Syndrome Evaluation (WISE) study. Because TFC is known to be higher in the left anterior descending artery (LAD), TFC determined in the LAD was divided by 1.7 to provide a corrected TFC (cTFC).
Results: A total of 298 women, with angiograms suitable for TFC analysis and long-term (6-10 year) follow up data, were included in this sub-study. Their age was 55±11 years, most were white (86%), half had a history of smoking, and half had a history of hypertension. Higher resting cTFC was associated with a higher rate of hospitalization for angina (34% in women with a cTFC >35, 15% in women with a cTFC ≤35, P<0.001). cTFC provided independent prediction of hospitalization for angina after adjusting for many baseline characteristics. In this cohort, resting cTFC was not predictive of major events (myocardial infarction, heart failure, stroke, or all-cause death), cardiovascular events, all-cause mortality, or cardiovascular mortality.
Conclusions: In women with signs and symptoms of ischemia but no obstructive CAD, resting cTFC provides independent prediction of hospitalization for angina. Larger studies are required to determine if resting TFC is predictive of major events in patients without obstructive coronary artery disease.
Conflict of interest statement
Figures
References
-
- Ong P, Athanasiadis A, Borgulya G, Mahrholdt H, Kaski JC, et al. (2012) High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol 59: 655–662. - PubMed
-
- Jespersen L, Hvelplund A, Abildstrøm SZ, Pedersen F, Galatius S, et al. (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33: 734–744. - PubMed
-
- Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, et al. (2009) Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 169: 843–850. - PMC - PubMed
-
- Reis SE, Holubkov R, Conrad Smith AJ, Kelsey SF, Sharaf BL, et al. (2001) Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J 141: 735–741. - PubMed
-
- von Mering GO, Arant CB, Wessel TR, McGorray SP, Bairey Merz CN, et al. (2004) Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109: 722–725. - PubMed
Publication types
MeSH terms
Grants and funding
- N01 HV068161/HV/NHLBI NIH HHS/United States
- U0164829/PHS HHS/United States
- R03 AG032631/AG/NIA NIH HHS/United States
- N01-HV-68164/HV/NHLBI NIH HHS/United States
- U01 HL649141/HL/NHLBI NIH HHS/United States
- U01 HL649241/HL/NHLBI NIH HHS/United States
- M01 RR000425/RR/NCRR NIH HHS/United States
- N01-HV-68163/HV/NHLBI NIH HHS/United States
- MO1-RR00425/RR/NCRR NIH HHS/United States
- N01 HV068162/HL/NHLBI NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- N01 HV068163/HL/NHLBI NIH HHS/United States
- T32 HL069751/HL/NHLBI NIH HHS/United States
- T32HL69751/HL/NHLBI NIH HHS/United States
- 1R03AG032631/AG/NIA NIH HHS/United States
- N01-HV-68161/HV/NHLBI NIH HHS/United States
- N01-HV-68162/HV/NHLBI NIH HHS/United States
- N01 HV068164/HV/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
